Elanco Animal Health (ELAN) Reports Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus
April 26, 2019 6:30 AM
Elanco Animal Health (NYSE: ELAN) today announced it has signed an agreement to acquire Aratana Therapeutics (NASDAQ: PETX), a pet ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)